跳至主要内容
临床试验/CTRI/2024/04/066075
CTRI/2024/04/066075尚未招募1/2 期

A RANDOMIZED CONTROLLED CLINICAL TRIAL OF HARITAKI AND SHUNTHI CHURNA BIDALAK IN VERNAL KERATO CONJUNCTIVITIS

DR SNEHA MOHOLKAR1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2024年4月30日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
56
试验地点
1
主要终点
The primary end point of study will be patient relieved from VERNAL KERATO CONJUNCTIVITIS without any complications

研究概览

简要总结

VERNAL KERATO CONJUNCTIVITIS is a type of allergic conjunctivitis.It is bilateral, recurrent occurs mainly in the childhood from 4-20 yrs of age.Occular allergy involves the surface of all ocular components.vernal KERATO conjunctivitis is common troublesome allergic conjunctivitis affecting mainly children and adolescent with seasonal recurrence.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
12.00 Year(s) 至 20.00 Year(s)(—)
性别
All

入选标准

  • Patient suffering from VERNAL KERATO CONJUNCTIVITIS.

排除标准

  • Existing occular surface pathology One eyed patients Post operative patients.

结局指标

主要结局

The primary end point of study will be patient relieved from VERNAL KERATO CONJUNCTIVITIS without any complications

时间窗: The primary end point of study will be patient relieved from VERNAL KERATO CONJUNCTIVITIS without any complications

次要结局

  • It is expected to equal or improved by 10% in parameters like itching burning sensation redness photophobia lacrimation(Baseline 3rd and 5th day)

研究者

发起方
DR SNEHA MOHOLKAR
申办方类型
Other [Other ( SELF)]
责任方
Principal Investigator
主要研究者

Dr Sneha Dnyaneshwar Moholkar

Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Pune

研究点 (1)

Loading locations...

相似试验

A LOCAL APPLICATION OF HARITAKI AND SHUNTHI CHURNA... | 临床试验